Search Results - "Cooper, Mark"

Refine Results
  1. 1

    Governing the global climate commons: The political economy of state and local action, after the U.S. flip-flop on the Paris Agreement by Cooper, Mark

    Published in Energy policy (01-07-2018)
    “…United States withdrawal from the Paris Agreement, which follows well-known principles of common pool resource management, poses a serious challenge, but it…”
    Get full text
    Journal Article
  2. 2

    Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future by Kahn, Steven E, Prof, Cooper, Mark E, Prof, Del Prato, Stefano, Prof

    Published in The Lancet (British edition) (22-03-2014)
    “…Summary Glucose metabolism is normally regulated by a feedback loop including islet β cells and insulin-sensitive tissues, in which tissue sensitivity to…”
    Get full text
    Journal Article
  3. 3

    Mechanisms of diabetic complications by Forbes, Josephine M, Cooper, Mark E

    Published in Physiological reviews (01-01-2013)
    “…It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic required, but also for its major complications, affecting both…”
    Get full text
    Journal Article
  4. 4

    New-Onset Diabetes in Covid-19 by Rubino, Francesco, Amiel, Stephanie A, Zimmet, Paul, Alberti, George, Bornstein, Stefan, Eckel, Robert H, Mingrone, Geltrude, Boehm, Bernhard, Cooper, Mark E, Chai, Zhonglin, Del Prato, Stefano, Ji, Linong, Hopkins, David, Herman, William H, Khunti, Kamlesh, Mbanya, Jean-Claude, Renard, Eric

    Published in New England Journal of Medicine (20-08-2020)
    “…Diabetes is associated with an increased risk of severe Covid-19. New-onset diabetes and metabolic complications of preexisting diabetes, including diabetic…”
    Get full text
    Journal Article Publication
  5. 5

    Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases by Hardy, Rowan S., Raza, Karim, Cooper, Mark S.

    Published in Nature reviews. Rheumatology (01-03-2020)
    “…Therapeutic glucocorticoids have been widely used in rheumatic diseases since they became available over 60 years ago. Despite the advent of more specific…”
    Get full text
    Journal Article
  6. 6

    Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease by Thomas, Merlin C., Cooper, Mark E., Zimmet, Paul

    Published in Nature reviews. Nephrology (01-02-2016)
    “…Key Points Chronic kidney disease (CKD) affects ∼50% of patients with type 2 diabetes mellitus (T2DM), and changes in the epidemiology of T2DM are driving…”
    Get full text
    Journal Article
  7. 7

    Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy by Hardy, Rowan S, Zhou, Hong, Seibel, Markus J, Cooper, Mark S

    Published in Endocrine reviews (01-10-2018)
    “…Osteoporosis associated with long-term glucocorticoid therapy remains a common and serious bone disease. Additionally, in recent years it has become clear that…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Breeding drought-tolerant maize hybrids for the US corn-belt: discovery to product by Cooper, Mark, Gho, Carla, Leafgren, Roger, Tang, Tom, Messina, Carlos

    Published in Journal of experimental botany (01-11-2014)
    “…Germplasm, genetics, phenotyping, and selection, combined with a clear definition of product targets, are the foundation of successful hybrid maize breeding…”
    Get full text
    Journal Article
  10. 10

    The Role of Advanced Glycation End Products in Progression and Complications of Diabetes by Goh, Su-Yen, Cooper, Mark E.

    “…Context: Diabetic complications appear to be multifactorial in origin, but in particular, the biochemical process of advanced glycation, which is accelerated…”
    Get full text
    Journal Article
  11. 11

    YB-1: the Jekyll and Hyde of kidney disease? by Kantharidis, Phillip, Cooper, Mark E

    Published in Kidney international (01-01-2024)
    “…Y-box-binding protein 1 is a well-described and important regulator of gene transcription, which is linked to various pathologic conditions, including…”
    Get more information
    Journal Article
  12. 12

    Epigenetics: Mechanisms and Implications for Diabetic Complications by Cooper, Mark E, El-Osta, Assam

    Published in Circulation research (10-12-2010)
    “…Epigenetic modifications regulate critical functions that underlie chromosome metabolism. Understanding the molecular changes to chromatin structure and the…”
    Get full text
    Journal Article
  13. 13

    miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7 by McClelland, Aaron D, Herman-Edelstein, Michal, Komers, Radko, Jha, Jay C, Winbanks, Catherine E, Hagiwara, Shinji, Gregorevic, Paul, Kantharidis, Phillip, Cooper, Mark E

    Published in Clinical science (1979) (01-12-2015)
    “…The cytokine transforming growth factor (TGF)-β1 plays a central role in diabetic nephropathy (DN) with data implicating the miRNA (miR) miR-21 as a key…”
    Get more information
    Journal Article
  14. 14

    Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes by FORBES, Josephine M, COUGHLAN, Melinda T, COOPER, Mark E

    Published in Diabetes (New York, N.Y.) (01-06-2008)
    “…Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes Josephine M. Forbes 1 2 , Melinda T. Coughlan 1 and Mark E. Cooper 1 2 1 Juvenile Diabetes…”
    Get full text
    Journal Article
  15. 15

    Diabetes and Kidney Disease: Role of Oxidative Stress by Jha, Jay C, Banal, Claudine, Chow, Bryna S M, Cooper, Mark E, Jandeleit-Dahm, Karin

    Published in Antioxidants & redox signaling (20-10-2016)
    “…Intrarenal oxidative stress plays a critical role in the initiation and progression of diabetic kidney disease (DKD). Enhanced oxidative stress results from…”
    Get more information
    Journal Article
  16. 16

    Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies by Warren, Annabelle M, Knudsen, Søren T, Cooper, Mark E

    Published in Expert opinion on therapeutic targets (03-07-2019)
    “…: Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in diabetes and is the most common cause of proteinuric and non-proteinuric forms…”
    Get more information
    Journal Article
  17. 17

    Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data by Liu, Jinli, Bai, Ruhai, Chai, Zhonglin, Cooper, Mark E., Zimmet, Paul Z., Zhang, Lei

    Published in Diabetologia (01-08-2022)
    “…Aims/hypothesis The study aims to quantify the global trend of the disease burden of type 2 diabetes caused by various risks factors by country income tiers…”
    Get full text
    Journal Article
  18. 18

    Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells by McNeill, Alisdair, Magalhaes, Joana, Shen, Chengguo, Chau, Kai-Yin, Hughes, Derralyn, Mehta, Atul, Foltynie, Tom, Cooper, J. Mark, Abramov, Andrey Y., Gegg, Matthew, Schapira, Anthony H.V.

    Published in Brain (London, England : 1878) (01-05-2014)
    “…Heterozygous GBA gene mutations are the most frequent Parkinson’s disease risk factor. Using Parkinson’s disease patient derived fibroblasts McNeill et al…”
    Get full text
    Journal Article
  19. 19

    Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes by Zoungas, Sophia, Woodward, Mark, Li, Qiang, Cooper, Mark E., Hamet, Pavel, Harrap, Stephen, Heller, Simon, Marre, Michel, Patel, Anushka, Poulter, Neil, Williams, Bryan, Chalmers, John

    Published in Diabetologia (01-12-2014)
    “…Aims/hypothesis Data are inconsistent regarding the associations between age, age at diagnosis of diabetes, diabetes duration and subsequent vascular…”
    Get full text
    Journal Article
  20. 20

    UKPDS and the Legacy Effect by Chalmers, John, Cooper, Mark E

    Published in The New England journal of medicine (09-10-2008)
    “…The United Kingdom Prospective Diabetes Study (UKPDS) continues to produce important evidence concerning the evolution of type 2 diabetes and its management…”
    Get full text
    Journal Article